BA

Bedard ADME-Tox Solutions at ACT 2026

Nov 15–18, 2026 San Antonio, TX ~1.4k attendees Website

Bedard ADME-Tox Solutions takes part in 2 sessions at ACT 2026 in San Antonio. Its sessions cover first-in-human dose selection and drugs for the brain. They explain model-informed ways to predict a safe starting dose in people and how to get a drug across the blood-brain barrier.

OrganizationACT 2026 Attendance
BA
Bedard ADME-Tox Solutions
Consultancies
ADME and toxicology consultancy presenting on model-informed first-in-human dose prediction and getting drugs into the brain.
Talk
Sun Nov 15
8:20am–8:45am
Part of First-in-Human Dose Selection: Translational Strategies and Special Considerations across Modalities and Organ Systems (CE1)
Model-Informed Approaches to FIH Dose Prediction (CE1-2)
Translational safety · with Tango Therapeutics
Talk
Tue Nov 17
9:05am–9:30am
Part of Overcoming the Blood-Brain Barrier and Translational Challenges in the Nonclinical Development of CNS Drugs (S08)
Beyond the Barrier: Unlocking Drug Penetration into the CNS (S08-2)
Neurotoxicology

Explore the full ACT 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in San Antonio. Leave your work email and we’ll be in touch.

Privacy

Download the full ACT 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Bedard ADME-Tox Solutions

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the American College of Toxicology (ACT). Organization details are derived from ACT’s published program, exhibitor floor plan and supporter list, and each organization’s own website. Submit a correction